Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 4 | SFE2002 | Next issue

193rd Meeting of the Society for Endocrinology and Society for Endocrinology joint Endocrinology and Diabetes Day

Poster Presentations

Diabetes, metabolism and cardiovascular

ea0004p36 | Diabetes, metabolism and cardiovascular | SFE2002


Kousta E , Efstathiadou Z , Lawrence N , Barrett S , Dore C , Johnston D , McCarthy M

We investigated the relationship between gestational diabetes (GDM) and the metabolic syndrome in 368 (185 European (EUR), 103 South Asian (SA) and 80 Afro-Caribbean (AC)) women studied 20.0 (18.2-22.1) months (mean (95% CI)) following a GDM pregnancy and 482 normoglycaemic women (288 EUR, 99 SA, 95 AC) with no history of GDM. Estimates of beta-cell function (%B) and insulin sensitivity (%S) were derived using the HOMA method. Analysis was by multiple linear regression includi...

ea0004p37 | Diabetes, metabolism and cardiovascular | SFE2002

Haemodynamic effects of acute buccal administration of testosterone in men with heart failure

Pugh P , Malkin C , Jones R , Channer K , Jones T

Background: Testosterone treatment has been shown to increase exercise capacity in men with chronic heart failure but the mechanism of benefit is unclear. The purpose of this study was to examine the acute haemodyamic effects of testosterone in men with heart failure.Methods: Twelve men with stable heart failure (age 62.8 (8.8)years; ejection fraction 30.9 (6.3)% (NR>60%)) were enrolled in a double-blind, placebo-controlled cross-over study. Cardiac o...

ea0004p38 | Diabetes, metabolism and cardiovascular | SFE2002

Sex difference in serum leptin concentrations in Chinese type 2 diabetic patients with or without nephropathy

Chan N , Chan W , Ma R , Ng M , Lee Z , Lai C , Tong P , So W , Chan J

Objectives: To investigate whether there is a sex difference in serum leptin concentration in Chinese Type 2 diabetic patients with and without nephropathy.Methods: Early morning fasting serum leptin concentrations were measured in 34 Type 2 diabetic patients (mean age 62.1) with nephropathy (creatinine 120-450micromol/l and spot urinary albumin creatinine ratio (ACR) > 25 mg/mmol), 12 newly diagnosed diabetic subjects (mean age 62.5) with normoalbumi...

ea0004p39 | Diabetes, metabolism and cardiovascular | SFE2002


Madrevica I , Ligere R , Krikis J

The incidence of cardiovascular diseases, diabetes mellitus and obesity is constantly growing in Latvia. Obesity in children is a globally progressing public health problem that can lead to serious metabolic abnormalities - insulin resistance and associated metabolic syndrome.Our objective was to determine the risk factors that contribute to the development of arterial hypertension in schoolchildren. 238 schoolboys between the ages of 7 and 19 were scree...

ea0004p40 | Diabetes, metabolism and cardiovascular | SFE2002


Mousa A , Knight G , Muzulu S , Rochester J

UNUSUAL PRESENTATION OF DIABETES FOOT ULCERAM Mousa, G Knight, S Muzulu, J R Rochester. Rotherham General Hospital, Moorgate Road, Rotherham S60 2UD.IntroductionPhalangeal metastases commonly display inflammatory symptoms that mimic an acute infection. We describe a rare case of bronchogenic carcinoma with metastases to the left 3rd and 4th toes, which presented as presumed diabetic foot ulceration.<p cla...

ea0004p41 | Diabetes, metabolism and cardiovascular | SFE2002


English P , Coughlin S , Hayden K , Malik I , Wilding J

Introduction. Adiponectin is a novel circulating adipocyte derived protein, whose plasma concentrations paradoxically decrease with increasing fat mass. Adiponectin has been shown to improve both glucose and lipid metabolism, and circulating concentrations are inversely correlated with insulin resistance. The factors regulating adiponectin expression and secretion are poorly understood. No study has previously examined the acute post-prandial regulation of adiponectin s...

ea0004p42 | Diabetes, metabolism and cardiovascular | SFE2002

New results of glucose tolerance test in people with a four-year history of impaired glucose tolerance in Zanjan province's rural areas

#FSh|#Sharifi|# , Jaberi Y , Agaii M , Soltani A

Background:With respect to what has been mentioned about the progression of IGT to overt diabetes, and the lack of information in rural areas, and also some unresolved questions about the relationship between IGT and some micro and macrovascular complications, this research was accomplished in the years 2001-2002.Material and Methods:The first step of this study was carried out in 1977 to screen people (1988 ...

ea0004p43 | Diabetes, metabolism and cardiovascular | SFE2002

Hyperleptinemia and cardiovascular diseases

Sieminska L , Kajdaniuk D , Kos-Kudla B , Marek B , Nowak M , Szelag-Glogowska J

Hyperleptinemia is associated with such risk factors for cardiovascular disease as insulin resistance, obesity and hypertension. Recently, it has been identified that leptin has prothrombotic properties and increases the accumulation of oxidant radicals in endothelial cells. It is hypothesized that leptin may be also one of the mediators promoting atherosclerosis.The objectives of the work were to:determine whether there are any co...

ea0004p44 | Diabetes, metabolism and cardiovascular | SFE2002

A Possible Role for Protein Kinase C Epsilon in Growth Hormone Signalling

Semple J , Pooley L , Vernon R

Growth hormone (GH) acts chronically to decrease adiposity, at least in part by the inhibition of lipogenesis. One or more of the twelve isoforms of Protein kinase C (PKC) may be involved in this chronic effect of GH on lipogenesis in adipocytes.Two approaches were adopted to examine the role of PKC isoforms in GH signalling. The first method involved maintaining explants of Finn/Dorset sheep adipose tissue with insulin, GH or a combination of both, for ...

ea0004p45 | Diabetes, metabolism and cardiovascular | SFE2002

Abstract Title: Lowering of Low Density Lipoprotein (LDL) cholesterol levels in patients followed in a diabetic clinic for 1-year period

Bhaghayath K , Simmons D

OBJECTIVE: To evaluate if follow up in a specialty clinic for Diabetics can result in lower LDL levels.METHODS: A Veterans Administration (VA) diabetes clinic established in 1996 consisted of 5 academic endocrinologists, nurse practitioner, endocrinology fellows, rotating medical housestaff, pharmacist, nutritionist and nurse. All patients enrolled in diabetes clinic for at least one year had their electronic medical record reviewed retrospectively for d...

ea0004p46 | Diabetes, metabolism and cardiovascular | SFE2002

Glucose intolerance in women with polycystic ovary syndrome

Sieminska L , Kos-Kudla B , Marek B , Kajdaniuk D , Foltyn W , Strzelczyk J , Staszewicz P

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age and is characterized by hyperandrogenism and menstrual disturbances. It is known that insulin resistance is associated with polycystic ovary syndrome and with obesity.The objective of this study was to assess the prevalence of glucose intolerance and diabetes in women with PCOS and to examine the role of body mass index in the development of this complications...

ea0004p47 | Diabetes, metabolism and cardiovascular | SFE2002

Characterisation of gene transfer to vascular cell lines using adenoassociated virus(AAV Serotype-2)

Sen S , Bartlett J , O'Brien T

BACKGROUND: Atherosclerosis is a major cause of mortality in diabetes mellitus. Gene therapy may be a useful approach to the treatment of this disorder. One of the main obstacles to the use of this therapeutic modality is the difficulty in obtaining safe and efficient gene transfer in vivo. Adenoassociated virus vector have been used in a number of previous studies but have never been used for vascular gene delivery. OBJECTIVE: Our goal was to characterize AAV mediated gene de...